戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rotonin transporter, and is unlikely to be a hallucinogen.
2 t little is known of how the CLA responds to hallucinogens.
3 erotonin receptor (5-HTR) agonists including hallucinogens.
4 on of both serotonergic and non-serotonergic hallucinogens.
5 of these scarcely characterized serotonergic hallucinogens.
6 phenethylamines derived from the 2C class of hallucinogens.
7 , which can be mimicked by administration of hallucinogens.
8 e one of the most potent naturally occurring hallucinogens.
9 anisms responsible for the unique effects of hallucinogens.
10 signaling pattern and behavioral response to hallucinogens.
11 ion of the more flexible phenethylamine type hallucinogens.
12 amate is a common mechanism in the action of hallucinogens.
13 become more widely used in the U.S. as legal hallucinogens.
14 get responsible for the actions of classical hallucinogens.
15 n, synthesize, extract, identify, and ingest hallucinogens.
16 c illness and the psychotomimetic effects of hallucinogens.
17 ast new light on the mechanisms of action of hallucinogens.
18 sedatives, stimulants, cocaine, opiates, and hallucinogens.
19 sed stereotypical behavioral response to the hallucinogen 2,5-dimethoxy-4-iodoamphetamine (DOI), an a
20 ed high prevalence of prior cocaine (35.5%), hallucinogen (49.4%), heroin (8.7%), and inhalant (30.4%
21 art in the behavioural effects of tryptamine hallucinogens(5), particularly 5-methoxy-N,N-dimethyltry
22 2A)R subtype has been shown to be central to hallucinogen action, yet the precise mechanisms mediatin
23 gs used in this context include serotonergic hallucinogens, amphetamine, and NMDA receptor antagonist
24 o controls consistent with its activity as a hallucinogen and a tremorogen.
25 ing-methylated derivatives of the well-known hallucinogen and entactogen MDA (1a) were synthesized an
26 ic acid diethylamide (LSD) is a prototypical hallucinogen and its psychedelic actions are exerted thr
27 ecstasy is currently classified as a type of hallucinogen and its withdrawal is not recognized in the
28 ions for the inactivity of 6-fluoro-DET as a hallucinogen and to determine the effects of fluorinatio
29                                         Both hallucinogens and 3,4-methylenedioxymethamphetamine (MDM
30 icy implications given the increasing use of hallucinogens and associated ED visits.
31 d essential role in mediating the actions of hallucinogens and atypical antipsychotic drugs at 5-HT(2
32 serotonin receptors respond to the action of hallucinogens and atypical antipsychotic drugs, we have
33 the principal molecular targets for LSD-like hallucinogens and atypical antipsychotic drugs.
34 t a low addictive potential similar to other hallucinogens and consistent with kappa opiate receptor
35 irus, with increased head-twitch response to hallucinogens and diminished antipsychotic-like effect o
36 ing in the mPFC to the behavioral actions of hallucinogens and further support the targeting of mGlu2
37                  The behavioral responses to hallucinogens and glutamate antipsychotics are both affe
38 receptor (GPCR) that mediates the effects of hallucinogens and is the target of a number of commonly
39 cts were identified for structurally similar hallucinogens and nonhallucinogens and found to correspo
40     Associations between ED visits involving hallucinogens and SSD were estimated using cause-specifi
41 togen because of its affinities to classical hallucinogens and stimulants.
42  lie in the characterization of serotonergic hallucinogens and the screening of these compounds in bi
43 LT, mescaline) and of a selected group of 2C hallucinogens and their corresponding NBOMes, with EC50
44            Why only certain 2AR agonists are hallucinogens and which neural circuits mediate their ef
45 ng middle-stage drugs (including stimulants, hallucinogens, and inhaled drugs) at t2 were increased f
46 ith such pharmacologically distinct ligands, hallucinogens, and nonhallucinogens obtained from all-at
47 The 5-HT(2A) receptor is a target of several hallucinogens, antipsychotics, anxiolytics, and antidepr
48 he signaling and behavioral responses to the hallucinogens are distinct.
49 ences between psychedelic and nonpsychedelic hallucinogens as well as entactogens, and their behavior
50             These results confirm the use of hallucinogens at a rock art site while calling into ques
51  receptor (5-HT2AR) is the target of classic hallucinogens, atypical antipsychotics, and psychoplasto
52 characterize the extent of information about hallucinogens available to Internet users.
53                                DMT acts as a hallucinogen, but its receptor target has been unclear.
54    Due to the possible metabolism of certain hallucinogens by MAO-A, which would cause a bias in the
55 utic potential, and in drugs of abuse (e.g., hallucinogens, central stimulants, empathogens), the lat
56                      Classic or serotonergic hallucinogens comprise the third largest number of repor
57 ed PFC population activity, the serotonergic hallucinogen DOI dose-dependently decreased population a
58             Unexpectedly, the phenethylamine hallucinogen, DOI, a partial agonist at 5-HT(2A/2C) rece
59 d mental health conditions, individuals with hallucinogen ED visits had a greater risk of SSD compare
60 esults have led to the widely held idea that hallucinogens elicit their effect by modulating synaptic
61                                          How hallucinogens exert their actions through KOR and how KO
62 es, including persistent migraine aura, post-hallucinogen flashback, or psychogenic disorder.
63 d receptor agonist and atypical dissociative hallucinogen found in Salvia divinorum.
64  discriminate serotonin-releasing agents and hallucinogens from saline.
65         Individuals with ED visits involving hallucinogens had a greater risk of being diagnosed with
66                       Interest in and use of hallucinogens has been increasing rapidly.
67 , unambiguous evidence of the consumption of hallucinogens has not been reported from any rock art si
68          A revamped interest in the study of hallucinogens has recently emerged, especially with rega
69 norin A, the most potent naturally occurring hallucinogen, has attracted an increasing amount of atte
70        Psychedelics, also known as classical hallucinogens, have been investigated for decades due to
71 n amphetamine, cannabis, club drug, cocaine, hallucinogen, heroin, nonheroin opioid, sedative/tranqui
72 rchers conducted extensive investigations of hallucinogens in the 1950s and 1960s.
73 otentially promising clinical application of hallucinogens in the treatment of anxiety reactive to ad
74 nd may contribute to the specific effects of hallucinogens in this class.
75 T cells in the DRN induced by phenethylamine hallucinogens in vivo.
76  of HTR2A bound to 25-CN-NBOH-a prototypical hallucinogen-in complex with an engineered Galphaq heter
77                                              Hallucinogens, including mescaline, psilocybin, and lyse
78  0.6 mg/kg, i.p.), which is a phenethylamine hallucinogen, increased glutamate to 206% above saline-t
79                                              Hallucinogens induce the head twitch response (HTR) in r
80                                              Hallucinogens induce the head-twitch response (HTR), a r
81 hallucinations are hallmarks of serotonergic hallucinogen-induced altered states of consciousness.
82 hallucinations of the blind), schizophrenia, hallucinogen-induced states and epilepsy.
83 ns Software categories (alcohol-, cannabis-, hallucinogen-, inhalant-, opioid-, sedative-, stimulant-
84 ies (disorders related to alcohol, cannabis, hallucinogens, inhalants, opioids, sedatives, stimulants
85                           The illicit use of hallucinogens is reemerging in the United States, especi
86 semisynthetic ergoline alkaloid analogue and hallucinogen, is a potent psychoplastogen with promising
87           Male gender, all substances except hallucinogens lifetime, obsessive compulsive disorder, p
88                                              Hallucinogens like lysergic acid diethylamide (LSD), psi
89                                              Hallucinogen-like activity was evaluated in the two-leve
90                                              Hallucinogen-like activity, evaluated in the two-lever d
91 valuated using in vivo behavioral assays for hallucinogen-like and 5-HT(1A) agonist activity and in v
92  DOI from saline were employed to assess the hallucinogen-like behavioral properties of these rigid t
93  receptors, making it one of the most potent hallucinogen-like phenylalkylamine derivatives reported
94                             The prototypical hallucinogen LSD acts via serotonin receptors, and here
95 y of representatives of different classes of hallucinogens (LSD, 5-MeO-DALT, mescaline) and of a sele
96                                          The hallucinogen lysergic acid diethylamide (LSD; 0.1 mg/kg,
97  report biochemical studies showing that the hallucinogen lysergic acid diethylamide, its precursor e
98 inctive profile compared with the prototypic hallucinogen lysergic acid diethylamide.
99    While a frequently raised concern is that hallucinogens may be associated with an increased risk o
100 enewed interest in the clinical potential of hallucinogens may lead people with depression to a gener
101 nderstanding of the response to serotonergic hallucinogens may provide mechanistic insights into perc
102                                              Hallucinogens mediate many of their psychoactive effects
103  aromatic methoxy groups in the prototypical hallucinogen, mescaline (1).
104 ction is strikingly similar to that of other hallucinogens, necessitating studies of direct compariso
105 uced by various related compounds, including hallucinogens (perceptual), entheogens (spiritual), and
106 , manic symptoms, cardiovascular events, and hallucinogen persisting perception disorder.
107  suicide, persistent psychotic disorders, or hallucinogen persisting perception disorders following a
108 the most commonly used behavioral readout of hallucinogen pharmacology.
109 sidered an integral component of ritualistic hallucinogen practices, attenuates 25I-NBOH induced HTR
110 f 11 days, and the group was subdivided into hallucinogen-preferring users (n = 10) and MDMA-preferri
111 , -32%); no significant changes were seen in hallucinogen-preferring users.
112                      Psilocybin, the natural hallucinogen produced by Psilocybe ("magic") mushrooms,
113 d the effects of acute administration of the hallucinogen psilocybin (.16 mg/kg) versus placebo on am
114                    Although the serotonergic hallucinogen psilocybin activates multiple serotonin (5-
115 After the deletion of Nurr1 in the CLA, both hallucinogen receptor expression and signaling are lost.
116 et search techniques, the authors located 81 hallucinogen-related sites and categorized the informati
117 e and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates was as
118 We will discuss marijuana, cocaine, opioids, hallucinogens, solvents and the newer so-called rave or
119 ic drugs, and activation of mGluR2 abolishes hallucinogen-specific signalling and behavioural respons
120 ur classes of psychoactive natural products: hallucinogens, stimulants, cannabinoids, and opioids.
121                                          The hallucinogens studied [d-lysergic acid diethylamide, psi
122                    Despite the resurgence of hallucinogen studies, the effects of kappa-opioid agonis
123 ists may lack the intoxicating properties of hallucinogens such as LSD.
124                                      Classic hallucinogens such as lysergic acid diethylamide are tho
125                               The effects of hallucinogens, such as psilocybin and mescaline, require
126 posed mechanism of action for phenethylamine hallucinogens, that such compounds must be full agonists
127   Given the potential therapeutic actions of hallucinogens, these findings could accelerate the disco
128                               The ability of hallucinogens to increase extracellular glutamate in the
129 gs and reduce the ability of psychotomimetic hallucinogens to increase glutamatergic transmission.
130 ortion with SSD at 3 years, 208 of 5217 with hallucinogen use [3.99%] vs 13 639 of 9 239 075 in the g
131 tudy, individuals with an ED visit involving hallucinogen use had a greater risk of developing an SSD
132          We found evidence that MDMA but not hallucinogen use is associated with changes in the cereb
133        For any drug use and for cannabis and hallucinogen use, model fitting suggested that twin rese
134 ut a partner had higher rates of alcohol and hallucinogen use, while those with same-sex sexual exper
135               An incident ED visit involving hallucinogen use.
136 17 (0.1%) had an incident ED visit involving hallucinogen use.
137 ncy sites offering cautionary material about hallucinogen use.
138                Using the Internet, potential hallucinogen users can bypass traditional channels of me
139        Emergency department visits involving hallucinogens were associated with an increased risk of
140 ividuals with an incident ED visit involving hallucinogens were compared with members of the general
141 Annual rates of incident ED visits involving hallucinogens were stable between 2008 and 2012 and then
142 ) and consumption of illicit drugs (five, no hallucinogens) were rare.
143                                     LSD is a hallucinogen with complex neurobiological and behavioral

 
Page Top